NICE have published their appraisal document for Tafamidis and the outcome is not favouable. for the full document, please clinck here. The BNCS and BNMS are producing recommedations and answers to the questions posed by NICE. Pfizer (makers of Tafamidis) sent out educational grant proposal for which we are applying - hopefully the two avenues combined will secure the treatmemt of amyloid in the UK.
Please take the survey here to help the effort